Lessons Learned From Going Public During The Dot Com Bubble And The Great Recession

Source: Life Science Leader

In this executive virtual roundtable (EVR) segment, David Perry, chairman and cofounder of Better Therapeutics, a digital therapeutics company, shares experiences of taking companies public pre-COVID-19. His first, Chemdex, happened during the dot com bubble of the late 1990s. Perry’s second, Anacor Pharmaceutical, took place near the end of the Great Recession, before eventually being acquired by a Big Pharma for billions.